11:30 am – 12:30 pm Friday, October 29

Joint Topic: Anticoagulation Therapy Anticoagulation Alphabet Soup: VKAs, LMWHs, and DOACs (214-1)

Treatment of thrombosis in pediatric patients presents many challenges. Thrombosis in pediatric patients has a wide range of etiologies, and researchers lack consensus about duration of therapy based on the thrombosis location and the presence of risk factors. Most patients under 18 years of age are treated with either parenteral low-molecular-weight heparins (LMWH) or vitamin K antagonists (VKAs).

Read more...
Speaker:
Ashleigh Brown, BSN RN CPN CPHON®
CNE Hours
1
RX Hours
0.25
2:15 – 3:15 pm Saturday, October 30

Treating Smarter, Not Harder: Abandoning Intensification and Replacing with Immunotherapy for Patients with Down Syndrome and B-ALL (C234)

coglogoChildren with Down syndrome (DS) have a striking predisposition for developing acute leukemia, with a 40-fold increased risk of developing acute lymphoblastic leukemia (ALL) compared to non-DS patients (Wadhwa et al, 2017). Approximately 3% of children with ALL have DS, and these children have inferior outcomes and higher rates of treatment-related mortality (TRM) and are at greater risk of relapse (Buitenkamp et al., 2014).

Read more...
5:00 – 6:00 pm Thursday, October 28

Lighting the Way in COG with MATCH: Targeted Therapies in Pediatric CNS Tumors (C211)

coglogoPediatric MATCH (Molecular Analysis for Therapy Choice) is a joint effort between the National Cancer Institute (NCI) and Children’s Oncology Group (COG) matching targeted therapies to specific tumor genomic sequencing in patients with relapsed or refractory solid tumors, non-Hodgkin lymphomas, brain tumors, and histiocytic disorders.

Read more...
5:00 – 6:00 pm Thursday, October 28

Paper Presentation: Child/Adolescent Cancer Treatment Experience — Do CSF Biomarkers Relate to Measures of Cognitive Function in Children During Maintenance Therapy for Leukemia? (210-3)

Children treated for acute lymphocytic leukemia (ALL) receive central nervous system–directed chemotherapy, which is a known risk factor for cognitive dysfunction. ALL chemotherapy treatment is also associated with changes in biomarkers of inflammation and oxidative stress, which may underlie changes in neurocognitive functioning.

Read more...
5:00 – 6:00 pm Thursday, October 28

Paper Presentation: Child/Adolescent Cancer Treatment Experience — Analysis of AYA Cancer Patient Priority Symptoms Using Text Mining Software (210-2)

The symptoms associated with cancer treatment are a major concern for the adolescent and young adult (AYA) population. Understanding these distinct symptom experiences, especially AYAs' priority symptoms—those that take the forefront of a patient’s concern—can support healthcare providers in providing personalized care.

Read more...
Speaker:
Kylie Bethards
CNE Hours
1
5:00 – 6: 00 pm Thursday, October 28

Paper Presentation: Child/Adolescent Cancer Treatment Experience — Qualitative Content Analysis of Daily Journaling by Children with Cancer Using a Game-Based App (210-1)

The consequences of cancer persist beyond the clinical setting. Resources to assess the child’s quality of life and markers of well-being outside of the clinical setting can support a more personalized approach to care. Color Me Healthy is a new, game-based symptom assessment app that was co-designed by children with cancer and pediatric oncology clinicians.

Read more...
Speaker:
Kaitlyn Fox, BSN RN
CNE Hours
1
3:30 – 4:30 pm Thursday, October 28

Paper Presentation: Parent/Caregiver Experience — A Systematic Review and Meta-Analytic Evaluation of Psychosocial Interventions in Parents of Children with Cancer: A Focus on Minority Outcomes (204-3)

Much progress has been made in developing interventions to address psychosocial distress in parents of children with cancer. Racial/ethnic minorities may be more prone to psychosocial distress, and little is known about intervention response among these parents. This systematic review and meta-analysis evaluated the efficacy of psychosocial interventions on anxiety and depression outcomes for parents of children with cancer, with a focus on racial/ethnic minorities. Read more...
3:30 – 4:30 pm Thursday, October 28

Paper Presentation: Parent/Caregiver Experience — An Exploration of Experiences with the COVID-19 Pandemic in Parents of Children with Cancer (204-2)

Coronavirus (COVID-19) is a global pandemic that has caused significant morbidity and mortality worldwide. The uncertainty of COVID-19 may lead to significant mental health consequences for childhood cancer survivors and children experiencing cancer treatment, as well as their parents.

Read more...
Speaker:
Micah Skeens, PhD APRN
CNE Hours
1
3:30 – 4:30 pm Thursday, October 28

Paper Presentation: Parent/Caregiver Experience — It Can Be Hard But It's Not Bad': Documenting Caregiver Perceptions of Benefits/Burdens to Participating in Pediatric Palliative Care Research (204-1)

Documenting the benefits and burdens of pediatric palliative care research on children and their families could yield new knowledge relevant to study methods and allay uneasiness among clinicians and institutional review board members about pediatric palliative care research.

Read more...
Speaker:
Cheryl Reggio, BN-PC RN CPON®
CNE Hours
1
Subscribe to this RSS feed